Skip to search formSkip to main contentSkip to account menu

oxilorphan

Known as: L-N-cyclopropylmethyl-3,14-dihydroxymorphinan 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Morphinans

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
Role of endogenous opioids in neurohypophysial function of man.
Studies were carried out in normal human subjects to determine the effect of two narcotic antagonists, oxilorphan and butorphanol… 
1979
1979
The pharmacology of 20681-S and 20682-S, 6-oxo-N-cyclopropylmethylmorphinans, as narcotic antagonist analgesics.
It has been demonstrated that L-3hydroxy-6-oxo-N-cyclopropylmethylmorphinan methansulfonate (20681-S) and L-3,14-dihydroxy-6-oxo… 
Highly Cited
1978
Highly Cited
1978
Inhibition of Oxytocin Release by Morphine and Its Analogs
Summary Two synthetic morphine analogs, butorphanol and oxilorphan have been found to inhibit suckling induced oxytocin (OT… 
1976
1976
Partial Agonist Properties and Toxicity of Oral Oxilorphan
Alternative pharmacologic adjuncts are needed for the management of opiate abuse. Oxilorphan, a narcotic antagonist, was studied… 
1976
1976
Clinical trial in post-addicts with oxilorphan (levo-BC-2605): a new narcotic antagonist.
1974
1974
Diuretic action of the narcotic antagonist oxilorphan
The narcotic antagonists oXilorphan and d,l‐cyclazocine increased urinary output without affecting fluid intake in 10 subjects on… 
1974
1974
Chapter 5. Abuse of CNS Agents
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)